Trials / Completed
CompletedNCT00583271
A Prospective Study of EUS Guided Celiac Block
A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 127 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | triamcinolone | 80mg of triamcinolone injected into the celiac ganglion during the EUS-CB |
| DRUG | 98% dehydrated alcohol | 10ml of 98% dehydrated alcohol injected into the celiac ganglion during the EUS-CB |
Timeline
- Start date
- 2002-06-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2007-12-31
- Last updated
- 2014-09-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00583271. Inclusion in this directory is not an endorsement.